Crossmark

Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-022-02884-w

Published Online: 2022-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Contreras-Yáñez, Irazú

Guaracha-Basáñez, Guillermo Arturo

Cuevas-Montoya, Maximiliano

de Jesús Hernández-Bautista, José

Pascual-Ramos, Virginia
License Information

Text and Data Mining valid from 2022-08-12

Version of Record valid from 2022-08-12
More Information

Article History

Received: 27 May 2022

Accepted: 26 July 2022

First Online: 12 August 2022

Declarations

:

: The study was approved by the Institutional Review Board of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán with the reference number IRE-274-10/11-1. All the patients provided written informed consent for clinical follow-ups when entering the clinic. They provided additional written permission to review each patient’s chart and present data in scientific publications.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below